Literature DB >> 18592135

Steroid-refractory severe hepatic failure in adult onset Still's disease responding to cyclosporine.

Takao Nagashima1, Yoko Aoki, Sachiko Onishi, Masahiro Iwamoto, Hitoaki Okazaki, Seiji Minota.   

Abstract

We report two Japanese women with severe hepatic dysfunction and adult onset Still's disease. A 51-year-old woman had been diagnosed with adult onset Still's disease 3 years earlier. She relapsed while on maintenance therapy with prednisolone and methotrexate. After induction of remission with methylprednisolone pulse therapy, indomethacin, and methotrexate, severe hepatic failure occurred. This patient lacked the typical symptoms of adult onset Still's disease. The second patient was a 32-year-old woman with typical adult onset Still's disease. Remission was induced by high-dose prednisolone and methylprednisolone pulse therapy plus cyclosporine. After she stopped cyclosporine, severe liver dysfunction occurred. In both patients, liver dysfunction occurred during high-dose steroid therapy, and oral cyclosporine (3 mg/kg per day) dramatically improved their liver function. When steroid-resistant severe hepatic failure occurs in patients with adult onset Still's disease, cyclosporine may be the immunosuppressant of choice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18592135     DOI: 10.1007/s10067-008-0950-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  15 in total

1.  Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still's disease.

Authors:  T Hoshino; A Ohta; D Yang; M Kawamoto; M Kikuchi; Y Inoue; S Kamizono; T Ota; K Itoh; K Oizumi
Journal:  J Rheumatol       Date:  1998-02       Impact factor: 4.666

2.  Liver transplant in adult Still's disease.

Authors:  M McFarlane; M Harth; W J Wall
Journal:  J Rheumatol       Date:  1997-10       Impact factor: 4.666

3.  Hemophagocytic syndrome and adult Still's disease associated with meningoencephalitis and unconsciousness.

Authors:  T Nishida; K Suzuki; N Kuwada; Y Nakamura; K Motoyoshi; K Kamakura
Journal:  Intern Med       Date:  2001-10       Impact factor: 1.271

4.  Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease.

Authors:  M Kawashima; M Yamamura; M Taniai; H Yamauchi; T Tanimoto; M Kurimoto; S Miyawaki; T Amano; T Takeuchi; H Makino
Journal:  Arthritis Rheum       Date:  2001-03

5.  Adult Still's disease: manifestations, disease course, and outcome in 62 patients.

Authors:  J Pouchot; J S Sampalis; F Beaudet; S Carette; F Décary; M Salusinsky-Sternbach; R O Hill; A Gutkowski; M Harth; D Myhal
Journal:  Medicine (Baltimore)       Date:  1991-03       Impact factor: 1.889

6.  Cyclosporin A in the treatment of adult onset Still's disease.

Authors:  A Marchesoni; G P Ceravolo; N Battafarano; A Rossetti; S Tosi; F Fantini
Journal:  J Rheumatol       Date:  1997-08       Impact factor: 4.666

Review 7.  Recognition and management of macrophage activation syndrome in juvenile arthritis.

Authors:  Alison Kelly; Athimalaipet V Ramanan
Journal:  Curr Opin Rheumatol       Date:  2007-09       Impact factor: 5.006

8.  Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages.

Authors:  An D Billiau; Tania Roskams; Rita Van Damme-Lombaerts; Patrick Matthys; Carine Wouters
Journal:  Blood       Date:  2004-10-05       Impact factor: 22.113

9.  Cyclosporin A in the treatment of adult Still's disease.

Authors:  K Shojania; A Chalmers; K Rangno
Journal:  J Rheumatol       Date:  1995-07       Impact factor: 4.666

10.  Adult-onset Still's disease with disseminated intravascular coagulation and multiple organ dysfunctions dramatically treated with cyclosporine A.

Authors:  Jae-Hong Park; Joong Ho Bae; Yeon-Soo Choi; Hye-Soon Lee; Jae-Bum Jun; Sungsoo Jung; Dae-Hyun Yoo; Sang-Cheol Bae; Tae-Hwan Kim
Journal:  J Korean Med Sci       Date:  2004-02       Impact factor: 2.153

View more
  6 in total

1.  Still disease and the liver-an underappreciated association.

Authors:  Kieron B L Lim; Thomas D Schiano
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-12

2.  Autoimmune hepatitis and adult-onset Still's disease: can they coexist?

Authors:  Takao Nagashima; Seiji Minota
Journal:  Clin Rheumatol       Date:  2010-01-26       Impact factor: 2.980

3.  Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab.

Authors:  Kazuko Matsumoto; Takao Nagashima; Shino Takatori; Yuta Kawahara; Masaki Yagi; Masahiro Iwamoto; Hitoaki Okazaki; Seiji Minota
Journal:  Clin Rheumatol       Date:  2009-01-30       Impact factor: 2.980

4.  Severe hyperferritinemia--a clue for severe hepatitis in a patient with adult-onset Still's disease.

Authors:  Rema Bishara; Yolanda Braun-Moscovici; Amir Dagan; Kohava Toledano; Tarek Saadi; Edmond Sabo; Alexandra Balbir-Gurman
Journal:  Clin Rheumatol       Date:  2014-11-22       Impact factor: 3.650

5.  Rare Manifestation of a Rare Disease, Acute Liver Failure in Adult Onset Still's Disease: Dramatic Response to Methylprednisolone Pulse Therapy-A Case Report and Review.

Authors:  Nalini Valluru; Venkata S Tammana; Michael Windham; Eyasu Mekonen; Rehana Begum; Andrew Sanderson
Journal:  Case Rep Med       Date:  2014-06-04

Review 6.  The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review.

Authors:  Cecilia Beatrice Chighizola; Voon H Ong; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 10.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.